Owner Merck Patent GmbH

Inventors Barbanton, Jacques; Guedat, Philippe; Kane, Peter; Dumas, Herve; Decerprit, Jacques; Foster, Richard J.; Wendt, Bernd; Ortholand, Jean-Yves; Collonges, Francois

Agent Davies Collison Cave

Pub. Number AU-B-2004253649

PCT Pub. Number WO2005/003128

Priority 03/07670 25.06.03 FR

Filing date 2 June 2004

Wipo publication date 13 January 2005

Acceptance publication date 24 September 2009

A61K 31/454 (2006.01)

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 491/10 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms